There are currently 15 million patients living with Heart Failure (HF) in Europe. Annual mortal risk for these patients is between 10% to 20%, higher than various cancers. HF patients, in particular those with (multiple) comorbidities, currently do not receive optimal medical therapy, leading to potentially avoidable specialist-visits and frequent hospitalizations, impaired quality of life or even life-threatening complications. All this results in high costs for society.
up to 20 %
Led by Erasmus Universitair Medisch Centrum Rotterdam, this pilot is focused on introducing personal healthcare concepts to the benefits of patients with HF. It will underline the impact of appropriated infrastructure to deploy eHealth applications for value-based healthcare. The goal is to reach optimal medical therapy in 100% of subjects.